Physician

Aida H Saliby, MD

According to 2025 Medicare claims, Aida Saliby, MD (NPI: 1053300905) practices endocrinology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is WEILL MEDICAL COLLEGE OF CORNELL (NPI: 1417071945; TIN: 131623978) and primary practice location at 10038-5327. Saliby is affiliated with the NewYork Quality Care (ACO ID: A2571), participating under the MSSP model.

Saliby's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 245 traditional Medicare patients, billed 1,269 HCPCS/CPT codes, and received $53,896 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,022 prescription claims across 295 beneficiaries totaling $1,118,381 in drug costs, led by Ozempic (Semaglutide). DME data shows 79 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $17,933 to $53,896. Similarly, Part D prescription costs have moved sharply higher in recent years, from $309,118 to $1,118,381. For DME billing, reported payments rose steadily, from $161 to $18,825.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	122	278	$17,933
2016	127	274	$20,693
2017	94	260	$25,627
2018	119	254	$28,204
2019	137	313	$32,243
2020	120	234	$19,996
2021	152	389	$31,893
2022	161	393	$33,690
2023	195	2,368	$36,231
2024	245	1,269	$53,896

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	180	1,874	$309,118
2016	203	1,944	$366,302
2017	134	1,077	$248,066
2018	159	1,392	$391,145
2019	170	1,572	$461,401
2020	175	1,636	$573,969
2021	222	1,606	$643,231
2022	257	1,538	$802,577
2023	269	1,806	$1,193,027
2024	295	2,022	$1,118,381

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	27	73	$1,465
2016	31	83	$1,434
2017	N/R	36	$459
2018	18	45	$886
2019	17	63	$856
2020	14	66	$5,892
2021	15	47	$677
2022	14	87	$11,080
2023	12	84	$14,870
2024	26	79	$17,914

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	54	54	$179
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	60	67	$164
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	134	194	$108
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	210	288	$15
36415	Insertion of needle into vein for collection of blood sample	78	99	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	133	7,426	$227,753
Mounjaro	Tirzepatide	134	6,404	$227,376
Jardiance	Empagliflozin	120	7,200	$135,897
Farxiga	Dapagliflozin Propanediol	62	4,020	$71,738
Evenity (2 Syringes)	Romosozumab-Aqqg	29	862	$66,856

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	15	57	$17,614
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	11	22	$300

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Aida H. Saliby, MD?

Tedicare shows public-source Medicare data for Aida H. Saliby, MD (NPI 1053300905), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aida H. Saliby, MD have ACO affiliation data?

Aida H. Saliby, MD is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571).

What billing organization is linked to Aida H. Saliby, MD?

Aida H. Saliby, MD is linked to WEILL MEDICAL COLLEGE OF CORNELL (billing NPI 1417071945) in the available physician profile data.

Does Aida H. Saliby, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.